ASH 2019: Summary, Thoughts, and Impressions

Jim Omel |

The entryway at #ASH19 Each ASH annual meeting has its own ‘flavor’ and emphasis regarding myeloma. I’ve been to several and remember the excitement of ASH2015 after our unprecedented elotuzumab, daratumumab, Ninlaro, “November to Remember.” Last year the emphasis was on early immunotherapy with BiTEs, CAR-T, and ADCs (antibody drug conjugates). This year ASH2019 was […]

Palliative Care vs. Hospice Care

Tiffany Williams |

I attended a session on palliative care, Billed Palliative Care and End of Life Care in Patients with Hematologic Malignancies presented by V. Rao from Warren Alpert Medical School of Brown University. I thought it was interesting that palliative care was not defined in the talk. I suppose the assumption was the audience knew the […]